UK: +44 (0)1223 264428
USA: +1 (650) 798 5134
Cambridge Design Partnership are pleased to announce that in the last financial year it has experienced its biggest growth yet, with sales increasing by over 35% and its staff of researchers, designers, scientists and engineers now exceeding 100.
Cambridge Design Partnership was founded by three engineers 21 years ago, to develop innovative new products for clients around the world in the healthcare and consumer sectors.
Mike Cane, one of the founding partners explained “Over the years we have grown organically and our success is the result of a lot of hard work and commitment from our talented team and loyal clients. Our growth has come from strong sales in continental Europe and the US with well over half of our business coming from these export markets. When we founded the company we wanted to be a leading international provider of product innovation services for healthcare and consumer products, and I think we can now say we have achieved this.
Over the last 3 years we have expanded our capabilities significantly to make CDP a ‘one stop shop’ for businesses like Unilever, Barclaycard and Merck Consumer Healthcare, who need to innovate and launch their next generation products quickly. While our strength has traditionally been in engineering development and product design, we now have strong teams working in the front end of innovation that help our customers optimise their innovation plans, and at the back end where our manufacturing engineering group sets up new processes and multinational supply chains. While not every project uses all of these capabilities, the sheer range of expertise we can deploy to solve innovation challenges benefits our clients across the board.
Matt Schumann, also a founding partner added, “Our growth in the US healthcare market this year has been a key part of our expansion. It is the result of many years investment in that market from which we have added several major accounts to our healthcare and diagnostics portfolio. For these customers, our recent investments in an ISO13485 quality system, in house R&D facilities and our healthcare and regulatory team, has enabled us to innovate effectively in this highly regulated and challenging market.”
Mike Beadman, the third founding partner concluded, “We are very optimistic about the future. We have grown the business diligently achieving over 20% year on year on average growth, always focusing on the long term and constantly investing to improve the services that we offer. We have an increasing number of loyal customers who choose us as their innovation partner year after year. Our growing skills and capabilities enable us to complete ever more challenging projects within tight timescales and budgets and I believe it is these factors that underpin our sustained growth. We look forward to an exciting 2017.”
Using smart packaging to support consumer trials
A novel approach to drug delivery to improve adherence and the patient experience
Stay up to date with all our work and our latest news by signing up to our newsletter.